Integra LifeSciences Holdings Corporation
IART
$22.24
-$1.71-7.14%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 281.70% | 13.76% | -277.99% | -116.54% | 1.73% |
| Total Depreciation and Amortization | 105.36% | -50.40% | 43.55% | -1.35% | 1.40% |
| Total Amortization of Deferred Charges | 4.87% | -8.56% | 4.43% | -2.44% | 1.13% |
| Total Other Non-Cash Items | -141.80% | 2.51% | -37.38% | 389.96% | -138.40% |
| Change in Net Operating Assets | -453.29% | 261.73% | 104.02% | -331.36% | 129.63% |
| Cash from Operations | 125.66% | -44.35% | 156.42% | -73.18% | 119.46% |
| Capital Expenditure | 0.16% | 0.21% | -92.09% | 36.97% | -87.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.96% | 283.39% | 72.74% | -17.76% | -707.58% |
| Cash from Investing | 59.13% | 96.77% | -497.05% | 5.70% | -643.52% |
| Total Debt Issued | 62.39% | -62.93% | -84.13% | 1,935.71% | -86.18% |
| Total Debt Repaid | 3.85% | 54.12% | -499.63% | 38.87% | 56.51% |
| Issuance of Common Stock | -- | -- | -100.00% | 2,743.56% | -65.65% |
| Repurchase of Common Stock | -1,424.56% | 99.66% | -1,504.13% | -894.27% | 99.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 64.10% | 78.76% | -126.14% | 5,305.75% | 86.13% |
| Foreign Exchange rate Adjustments | -204.85% | 788.62% | 77.33% | -161.74% | 264.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39,616.46% | 99.98% | -219.39% | 11,716.63% | 107.53% |
